21 CFR 211.180 - General Requirements - Records Retention and Annual Review

What it says

Records must be retained for at least one year after the expiration date of the batch, or in some cases longer, and manufacturers must review a representative number of batches annually to evaluate quality standards and determine the need for changes, commonly implemented as the Annual Product Quality Review.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

• Records retention periods are calculated from whichever applicable trigger date, expiry or distribution, produces the longer retention obligation, not simply a flat one-year rule in every case.
• The annual review requirement under 211.180(e) is where deviation trends, complaint trends, and stability data are all expected to come together into one connected quality conclusion, not remain as separate, disconnected reports.
• A representative sample of batches, not every batch, is reviewed annually, but the sampling approach itself must be documented and defensible.

What FDA inspectors look for

• Whether the Annual Product Quality Review genuinely synthesises trend data across deviations, complaints, OOS results and stability, rather than simply restating each system's individual annual summary side by side.
• Whether conclusions from the annual review actually drive documented follow-up action when a trend is identified, rather than being filed without further action.
• Whether records are retrievable and legible for the full required retention period, not just recently generated records.

Related regulations